Nada Abou-Fayssal – Press/Media — Icahn School of Medicine at Mount Sinai

View Scopus Profile

h-index

Research activity per year

12 results
- Title
- Date(ascending)

Cancer Med, Rituximab, Might Be Powerful Treatment for MS
Abou-Fayssal, N.
19/07/22
1 item of Media coverage
Press/Media
Cancer Med Might Be Powerful Treatment for MS
Abou-Fayssal, N.
15/07/22
1 item of Media coverage
Press/Media
Cancer Med Might Be Powerful Treatment for MS.(multiple sclerosis)
Abou-Fayssal, N.
14/07/22
1 item of Media coverage
Press/Media
Cancer Med, Rituximab, Might Be Powerful Treatment for MS
Abou-Fayssal, N.
14/07/22
3 items of Media coverage
Press/Media
Cancer Med Might Be Powerful Treatment for MS
Abou-Fayssal, N.
14/07/22
159 items of Media coverage
Press/Media
COVID-19 Frequently Causes Neurological Injuries
Abou-Fayssal, N.
14/10/20
1 item of Media coverage
Press/Media
NYU Langone Health: COVID-19 Frequently Causes Neurological Injuries
Abou-Fayssal, N.
14/10/20
1 item of Media coverage
Press/Media
NYU Langone: COVID-19 Frequently Causes Neurological Injuries
Abou-Fayssal, N.
13/10/20
1 item of Media coverage
Press/Media
NYU Langone Health: COVID-19 Frequently Causes Neurological Injuries
Abou-Fayssal, N.
13/10/20
9 items of Media coverage
Press/Media
NYU Langone Health: COVID-19 Frequently Causes Neurological Injuries
Abou-Fayssal, N.
13/10/20
1 item of Media coverage
Press/Media
NYU Langone Health: COVID-19 Frequently Causes Neurological Injuries
Abou-Fayssal, N.
13/10/20
1 item of Media coverage
Press/Media
Nyu Langone Brooklyn Neurology
Abou-Fayssal, N. & Ashina, S.
3/10/19
1 item of Media coverage
Press/Media